Medicine and Health

Plasma proteomic profiles predict individual future health risk

J. You, Y. Guo, et al.

A revolutionary proteomic risk score (ProRS) was developed by Jia You, Yu Guo, Yi Zhang, Ju-Jiao Kang, Lin-Bo Wang, Jian-Feng Feng, Wei Cheng, and Jin-Tai Yu, leveraging a vast dataset of 52,006 UK Biobank participants. This cutting-edge method not only stratifies the risk for a multitude of diseases, including cancer and dementia, but also surpasses conventional clinical indicators. Independent validation may soon pave the way for its real-world application.